Congratulations!

[Valid RSS] This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

Source: http://www.mayoclinicproceedings.org/current.rss

  1. <?xml version="1.0" encoding="UTF-8"?>
  2. <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  3.         xmlns="http://purl.org/rss/1.0/"
  4.         xmlns:dc="http://purl.org/dc/elements/1.1/"
  5.         xmlns:dcterms="http://purl.org/dc/terms/"
  6.         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
  7.         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  8.         xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# uri:atypon.com:cms:schema:rdf.xsd">
  9.   <channel rdf:about="https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes">
  10.      <title>Mayo Clinic Proceedings</title>
  11.      <description>Mayo Clinic Proceedings RSS feed. </description>
  12.      <link>https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes</link>
  13.      <dc:publisher>Elsevier Inc.</dc:publisher>
  14.      <dc:language>en</dc:language>
  15.      <dc:rights>© 2025 Published by Elsevier Inc. All rights reserved.</dc:rights>
  16.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  17.      <prism:issn>0025-6196</prism:issn>
  18.      <prism:publicationDate>2025-05-03-07:00</prism:publicationDate>
  19.      <prism:copyright>© 2025 Published by Elsevier Inc. All rights reserved.</prism:copyright>
  20.      <prism:rightsAgent>permissionshelpdesk@elsevier.com</prism:rightsAgent>
  21.      <items>
  22.         <rdf:Seq>
  23.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00143-0/fulltext?rss=yes"/>
  24.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00080-1/fulltext?rss=yes"/>
  25.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00436-1/fulltext?rss=yes"/>
  26.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00434-8/fulltext?rss=yes"/>
  27.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00152-1/fulltext?rss=yes"/>
  28.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00151-X/fulltext?rss=yes"/>
  29.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00435-X/fulltext?rss=yes"/>
  30.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00100-4/fulltext?rss=yes"/>
  31.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00622-0/fulltext?rss=yes"/>
  32.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00693-1/fulltext?rss=yes"/>
  33.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00668-2/fulltext?rss=yes"/>
  34.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00364-1/fulltext?rss=yes"/>
  35.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00081-3/fulltext?rss=yes"/>
  36.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00048-5/fulltext?rss=yes"/>
  37.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00650-5/fulltext?rss=yes"/>
  38.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00623-2/fulltext?rss=yes"/>
  39.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00142-9/fulltext?rss=yes"/>
  40.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00113-2/fulltext?rss=yes"/>
  41.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00083-7/fulltext?rss=yes"/>
  42.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00047-3/fulltext?rss=yes"/>
  43.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00363-X/fulltext?rss=yes"/>
  44.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00488-9/fulltext?rss=yes"/>
  45.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00696-7/fulltext?rss=yes"/>
  46.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00692-X/fulltext?rss=yes"/>
  47.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00686-4/fulltext?rss=yes"/>
  48.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00075-8/fulltext?rss=yes"/>
  49.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00482-8/fulltext?rss=yes"/>
  50.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00479-8/fulltext?rss=yes"/>
  51.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00480-4/fulltext?rss=yes"/>
  52.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00618-9/fulltext?rss=yes"/>
  53.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00663-3/fulltext?rss=yes"/>
  54.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00481-6/fulltext?rss=yes"/>
  55.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00666-9/fulltext?rss=yes"/>
  56.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00616-5/fulltext?rss=yes"/>
  57.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00615-3/fulltext?rss=yes"/>
  58.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00216-2/fulltext?rss=yes"/>
  59.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00190-9/fulltext?rss=yes"/>
  60.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00189-2/fulltext?rss=yes"/>
  61.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00188-0/fulltext?rss=yes"/>
  62.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00180-6/fulltext?rss=yes"/>
  63.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00149-1/fulltext?rss=yes"/>
  64.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00148-X/fulltext?rss=yes"/>
  65.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00147-8/fulltext?rss=yes"/>
  66.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00146-6/fulltext?rss=yes"/>
  67.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00145-4/fulltext?rss=yes"/>
  68.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00144-2/fulltext?rss=yes"/>
  69.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00114-4/fulltext?rss=yes"/>
  70.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00101-6/fulltext?rss=yes"/>
  71.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00097-7/fulltext?rss=yes"/>
  72.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00082-5/fulltext?rss=yes"/>
  73.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00664-5/fulltext?rss=yes"/>
  74.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00365-3/fulltext?rss=yes"/>
  75.         </rdf:Seq>
  76.      </items>
  77.   </channel>
  78.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00143-0/fulltext?rss=yes">
  79.      <title>Tuberculous Empyema Necessitans</title>
  80.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00143-0/fulltext?rss=yes</link>
  81.      <description>A man in his late 20s from the Midwest region of the United States was referred to our clinic with a draining ulcer on his back. Eighteen months prior to presentation, the patient completed a 12-month course of therapy for pleural tuberculosis, which was associated with a small right-sided pleural effusion that had persisted despite therapy (Figure A). On examination in our office, the patient had a large ulcerating lesion on the right chest wall, exhibiting active purulent exudate (Figure B). Computed tomography of the chest revealed a loculated right-sided pleural effusion with extension into the surrounding soft tissue structures (Figure C).</description>
  82.      <dc:title>Tuberculous Empyema Necessitans</dc:title>
  83.      <dc:creator>Jack McHugh, Supavit Chesdachai</dc:creator>
  84.      <dc:identifier>10.1016/j.mayocp.2025.03.003</dc:identifier>
  85.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  86.      <dc:date>2025-05-03</dc:date>
  87.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  88.      <prism:publicationDate>2025-05-03</prism:publicationDate>
  89.      <prism:section>Medical image</prism:section>
  90.   </item>
  91.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00080-1/fulltext?rss=yes">
  92.      <title>Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management</title>
  93.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00080-1/fulltext?rss=yes</link>
  94.      <description>Autosomal dominant polycystic kidney disease (ADPKD), the most prevalent genetic kidney disorder, is characterized by diffuse kidney cysts, hypertension, and progressive kidney function decline, often leading to kidney failure by the age of 60 years. Compared with the general population, patients with ADPKD have an increased risk for development of saccular intracranial aneurysms (IAs), which can lead to intracranial bleeding and result in significant disability and mortality. Of both modifiable and nonmodifiable risk factors, the most significant is a family history of IAs or aneurysm rupture.</description>
  95.      <dc:title>Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management</dc:title>
  96.      <dc:creator>Abdul Hamid Borghol, Bassel Alkhatib, Roaa Zayat, Naveen P.G. Ravikumar, Fadi George Munairdjy Debeh, Ahmad Ghanem, Jonathan Mina, Michael A. Mao, Neera K. Dahl, LaTonya J. Hickson, Nabeel Aslam, Vicente E. Torres, Robert D. Brown, Rabih G. Tawk, Fouad T. Chebib</dc:creator>
  97.      <dc:identifier>10.1016/j.mayocp.2025.02.003</dc:identifier>
  98.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  99.      <dc:date>2025-05-03</dc:date>
  100.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  101.      <prism:publicationDate>2025-05-03</prism:publicationDate>
  102.      <prism:section>Review</prism:section>
  103.   </item>
  104.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00436-1/fulltext?rss=yes">
  105.      <title>69-Year-Old Man With Acute Kidney Injury</title>
  106.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00436-1/fulltext?rss=yes</link>
  107.      <description>A 69-year-old man with past medical history notable for hepatitis C (genotype 2) cirrhosis complicated by hepatocellular carcinoma treated with sofosbuvir and ribavirin with partial hepatectomy, recurrent ascites requiring weekly paracentesis, and esophageal varices status post ligation presented to the emergency department after a routine hepatology office visit because of hypotension. The patient reported dyspnea, lightheadedness, mild abdominal distention, 2 loose bowel movements daily, intermittent chills without fever, and progressive fatigue during the past 2 weeks.</description>
  108.      <dc:title>69-Year-Old Man With Acute Kidney Injury</dc:title>
  109.      <dc:creator>William M. Schmidt, Christopher B. Parker, Benjamin J. McCormick</dc:creator>
  110.      <dc:identifier>10.1016/j.mayocp.2024.05.037</dc:identifier>
  111.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  112.      <dc:date>2025-05-03</dc:date>
  113.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  114.      <prism:publicationDate>2025-05-03</prism:publicationDate>
  115.      <prism:section>Residents’ clinic</prism:section>
  116.   </item>
  117.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00434-8/fulltext?rss=yes">
  118.      <title>56-Year-Old Man With Abdominal Pain, Decreased Urine Output, Nausea, and Vomiting</title>
  119.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00434-8/fulltext?rss=yes</link>
  120.      <description>A 56-year-old man presented to the emergency department for evaluation of abdominal pain. He has a history of type 2 diabetes mellitus, pancreatitis, hypothyroidism, peripheral artery disease, chronic kidney disease stage 4, hypertriglyceridemia, and coronary artery disease. Home medications include amlodipine, aspirin, chlorthalidone, cholecalciferol, fenofibrate, glimepiride, guanfacine, lisinopril-hydrochlorothiazide, spironolactone, metoprolol succinate, pregabalin, sertraline, atorvastatin, levothyroxine, and torsemide.</description>
  121.      <dc:title>56-Year-Old Man With Abdominal Pain, Decreased Urine Output, Nausea, and Vomiting</dc:title>
  122.      <dc:creator>Julia D. Liberto, Ahsan Butt, M. Nadir Bhuiyan</dc:creator>
  123.      <dc:identifier>10.1016/j.mayocp.2024.05.036</dc:identifier>
  124.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  125.      <dc:date>2025-05-03</dc:date>
  126.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  127.      <prism:publicationDate>2025-05-03</prism:publicationDate>
  128.      <prism:section>Residents’ Clinic</prism:section>
  129.   </item>
  130.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00152-1/fulltext?rss=yes">
  131.      <title>Hepatic Portal Venous Gas</title>
  132.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00152-1/fulltext?rss=yes</link>
  133.      <description>An adolescent boy with a history of perianal abscess and anal fistula presented to the gastroenterology department complaining of intermittent abdominal pain and diarrhea for 1 year. Physical examination showed no abnormalities. Colonoscopy revealed deep fissuring ulcers and friability from ileocecal junction to splenic flexure, suggesting a diagnosis of Crohn disease (Figure A). He suffered from a fever (temperature peaked at 38.5 °C) without abdominal pain after colonoscopy. Laboratory examination showed white blood cell counts up to 20.5 × 109/L.</description>
  134.      <dc:title>Hepatic Portal Venous Gas</dc:title>
  135.      <dc:creator>Shengduo He, Jing Liu, Jinpei Dong</dc:creator>
  136.      <dc:identifier>10.1016/j.mayocp.2025.03.012</dc:identifier>
  137.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  138.      <dc:date>2025-05-02</dc:date>
  139.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  140.      <prism:publicationDate>2025-05-02</prism:publicationDate>
  141.      <prism:section>Medical image</prism:section>
  142.   </item>
  143.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00151-X/fulltext?rss=yes">
  144.      <title>Skeeter Syndrome With Bullous Lesions</title>
  145.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00151-X/fulltext?rss=yes</link>
  146.      <description>A man in his mid-60s presented to the allergy clinic for progressively worsening cutaneous reactions to arthropod bites during the last 7 years. His history was notable for marginal zone B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride [hydroxydaunorubicin], vincristine sulfate [Oncovin], and prednisone), with subsequent surveillance imaging demonstrating stable disease. Within 24 to 48 hours of sustaining arthropod bites, he experienced large bullous lesions (Figure 1) that often required prednisone for treatment.</description>
  147.      <dc:title>Skeeter Syndrome With Bullous Lesions</dc:title>
  148.      <dc:creator>Raymond Lay, Carilyn Wieland, Sergio E. Chiarella</dc:creator>
  149.      <dc:identifier>10.1016/j.mayocp.2025.03.011</dc:identifier>
  150.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  151.      <dc:date>2025-05-02</dc:date>
  152.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  153.      <prism:publicationDate>2025-05-02</prism:publicationDate>
  154.      <prism:section>Medical image</prism:section>
  155.   </item>
  156.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00435-X/fulltext?rss=yes">
  157.      <title>39-Year-Old Man With Reflux, Diarrhea, and Abdominal Pain</title>
  158.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00435-X/fulltext?rss=yes</link>
  159.      <description>A 39-year-old man presented to the gastroenterology clinic with a 2-year history of progressive gastroesophageal reflux, abdominal discomfort, and diarrhea. He first began experiencing heartburn and watery diarrhea about 11 years earlier. Esophagogastroduodenoscopy (EGD) at symptom onset was unremarkable, and he was prescribed daily proton pump inhibitor (PPI) therapy. His symptoms improved, and he continued PPI therapy for about 11 years.</description>
  160.      <dc:title>39-Year-Old Man With Reflux, Diarrhea, and Abdominal Pain</dc:title>
  161.      <dc:creator>Hannah R. Phillips, June Tome, Conor G. Loftus</dc:creator>
  162.      <dc:identifier>10.1016/j.mayocp.2024.06.015</dc:identifier>
  163.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  164.      <dc:date>2025-05-02</dc:date>
  165.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  166.      <prism:publicationDate>2025-05-02</prism:publicationDate>
  167.      <prism:section>Residents’ Clinic</prism:section>
  168.   </item>
  169.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00100-4/fulltext?rss=yes">
  170.      <title>Muscle Power Versus Strength as a Predictor of Mortality in Middle-Aged and Older Men and Women</title>
  171.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00100-4/fulltext?rss=yes</link>
  172.      <description>To assess whether muscle power (force times velocity) outperforms strength as a risk indicator and predictor of mortality.</description>
  173.      <dc:title>Muscle Power Versus Strength as a Predictor of Mortality in Middle-Aged and Older Men and Women</dc:title>
  174.      <dc:creator>Claudio Gil S. Araújo, Setor K. Kunutsor, Thijs M.H. Eijsvogels, Jonathan Myers, Jari A. Laukkanen, Dusan Hamar, Josef Niebauer, Atanu Bhattacharjee, Christina G. de Souza e Silva, João Felipe Franca, Claudia Lucia B. Castro</dc:creator>
  175.      <dc:identifier>10.1016/j.mayocp.2025.02.015</dc:identifier>
  176.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  177.      <dc:date>2025-04-30</dc:date>
  178.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  179.      <prism:publicationDate>2025-04-30</prism:publicationDate>
  180.      <prism:section>Original article</prism:section>
  181.   </item>
  182.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00622-0/fulltext?rss=yes">
  183.      <title>Impact of Sleeve Gastrectomy on Kidney Function and Preemptive Transplant in Kidney Transplant Candidates With Obesity</title>
  184.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00622-0/fulltext?rss=yes</link>
  185.      <description>To compare the impact of sleeve gastrectomy (SG) on kidney function, comorbidities, and kidney transplant (KT) rates in KT candidates with obesity with a nonsurgical cohort.</description>
  186.      <dc:title>Impact of Sleeve Gastrectomy on Kidney Function and Preemptive Transplant in Kidney Transplant Candidates With Obesity</dc:title>
  187.      <dc:creator>Pavel Navratil, Sukhdeep S. Sahi, Byron H. Smith, Aleksandar Denic, Naim S. Issa, Danielle Heyer, Teresa Marzlof, Afsana A. Shaik, Carrie A. Schinstock, Omar M. Ghanem, Mark D. Stegall, Lilach O. Lerman, Meera Shah, Pankaj Shah, Yogish C. Kudva, Tayyab S. Diwan, Aleksandra Kukla</dc:creator>
  188.      <dc:identifier>10.1016/j.mayocp.2024.10.024</dc:identifier>
  189.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  190.      <dc:date>2025-04-30</dc:date>
  191.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  192.      <prism:publicationDate>2025-04-30</prism:publicationDate>
  193.      <prism:section>Original article</prism:section>
  194.   </item>
  195.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00693-1/fulltext?rss=yes">
  196.      <title>Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor–Related Myocarditis</title>
  197.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00693-1/fulltext?rss=yes</link>
  198.      <description>To evaluate the incidence, timing, and characteristics of immune checkpoint inhibitor–related myocarditis (ICIrM) and associated cardiovascular events at 3-year follow-up.</description>
  199.      <dc:title>Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor–Related Myocarditis</dc:title>
  200.      <dc:creator>Milagros Pereyra Pietri, Juan M. Farina, Isabel G. Scalia, Michael Roarke, Ahmed K. Mahmoud, Rajeev Masson, Beman Wasef, Cecilia Tagle-Cornell, Courtney R. Kenyon, Mohammed Tiseer Abbas, Nima Baba Ali, Kamal Awad, Moaz A. Kamel, Ebram F. Said, Michael O’Shea, Timothy Barry, Hema Narayanasamy, Jordan C. Ray, Hicham El Masry, Carolyn M. Larsen, Joerg Herrmann, Reza Arsanjani, Chadi Ayoub</dc:creator>
  201.      <dc:identifier>10.1016/j.mayocp.2024.12.017</dc:identifier>
  202.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  203.      <dc:date>2025-04-09</dc:date>
  204.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  205.      <prism:publicationDate>2025-04-09</prism:publicationDate>
  206.      <prism:section>Original article</prism:section>
  207.   </item>
  208.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00668-2/fulltext?rss=yes">
  209.      <title>Changes in Burnout and Satisfaction With Work–Life Integration in Physicians and the General US Working Population Between 2011 and 2023</title>
  210.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00668-2/fulltext?rss=yes</link>
  211.      <description>To evaluate the prevalence of burnout and satisfaction with work–life integration (WLI) among physicians and US workers in 2023 relative to 2011, 2014, 2017, and 2020, as well as physicians in 2021.</description>
  212.      <dc:title>Changes in Burnout and Satisfaction With Work–Life Integration in Physicians and the General US Working Population Between 2011 and 2023</dc:title>
  213.      <dc:creator>Tait D. Shanafelt, Colin P. West, Christine Sinsky, Mickey Trockel, Michael Tutty, Hanhan Wang, Lindsey E. Carlasare, Liselotte N. Dyrbye</dc:creator>
  214.      <dc:identifier>10.1016/j.mayocp.2024.11.031</dc:identifier>
  215.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  216.      <dc:date>2025-04-09</dc:date>
  217.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  218.      <prism:publicationDate>2025-04-09</prism:publicationDate>
  219.      <prism:section>Original article</prism:section>
  220.   </item>
  221.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00364-1/fulltext?rss=yes">
  222.      <title>60-Year-Old Man With Low Hemoglobin and Elevated Creatinine Levels</title>
  223.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00364-1/fulltext?rss=yes</link>
  224.      <description>A 60-year-old man with a medical background of hyperlipidemia (not receiving lipid-lowering therapy), supraventricular tachycardia (SVT) treated with metoprolol, cholangiocarcinoma (complicated by jaundice and ascites requiring large-volume paracenteses), and nausea (treated with olanzapine) was directly admitted to the inpatient oncology service at the request of outpatient oncology for an increased serum creatinine level. He had completed 2 cycles of 1500-mg durvalumab, 49-mg cisplatin, and 1400-mg gemcitabine chemotherapy, with the last cycle 5 weeks before presentation.</description>
  225.      <dc:title>60-Year-Old Man With Low Hemoglobin and Elevated Creatinine Levels</dc:title>
  226.      <dc:creator>Daniel Montes, Samiddhi D. Weerasiri, Maria Gonzalez Suarez</dc:creator>
  227.      <dc:identifier>10.1016/j.mayocp.2024.05.034</dc:identifier>
  228.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  229.      <dc:date>2025-04-09</dc:date>
  230.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  231.      <prism:publicationDate>2025-04-09</prism:publicationDate>
  232.      <prism:volume>100</prism:volume>
  233.      <prism:number>5</prism:number>
  234.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  235.      <prism:section>Residents’ Clinic</prism:section>
  236.      <prism:startingPage>895</prism:startingPage>
  237.      <prism:endingPage>899</prism:endingPage>
  238.   </item>
  239.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00081-3/fulltext?rss=yes">
  240.      <title>Persistent Gender Gap in the Authorship of Hematology/Oncology Clinical Trials During the Past Two Decades</title>
  241.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00081-3/fulltext?rss=yes</link>
  242.      <description>Less than one-third of all hematology/oncology-related articles have a female author.1 Several hypotheses have been proposed to explain this gender gap, including the "leaky pipeline" from medical school to professorship, lower self-efficacy, and gender norms.2 Although targeted interventions to increase women in leadership positions have been proposed owing to strong gender concordance between first and senior authors,3 the impact of such interventions is likely to be slow because of the time needed to mentor female physician-scientists into leadership positions, who will mentor more female physician-scientists.</description>
  243.      <dc:title>Persistent Gender Gap in the Authorship of Hematology/Oncology Clinical Trials During the Past Two Decades</dc:title>
  244.      <dc:creator>Subhash Chander, Roopa Kumari, Milan Khealani, Om Parkash, FNU Sindhu, Sheena Shiwlani, FNU Sorath</dc:creator>
  245.      <dc:identifier>10.1016/j.mayocp.2025.02.004</dc:identifier>
  246.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  247.      <dc:date>2025-04-08</dc:date>
  248.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  249.      <prism:publicationDate>2025-04-08</prism:publicationDate>
  250.      <prism:volume>100</prism:volume>
  251.      <prism:number>5</prism:number>
  252.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  253.      <prism:section>Research letter</prism:section>
  254.      <prism:startingPage>913</prism:startingPage>
  255.      <prism:endingPage>916</prism:endingPage>
  256.   </item>
  257.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00048-5/fulltext?rss=yes">
  258.      <title>Fast-Tracking Renal Failure: A Classic Case of ANCA-Associated Glomerulonephritis</title>
  259.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00048-5/fulltext?rss=yes</link>
  260.      <description>A woman in her eighth decade of life with type 2 diabetes and stage 3b chronic kidney disease presented with nausea, weakness, and subjective fevers of 2 weeks’ duration. Laboratory studies revealed elevated levels of serum urea nitrogen (105 mg/dL) and creatinine (9.18 mg/dL; baseline, 1.5 mg/dL). Urinalysis identified pyuria and hematuria without dysmorphic red blood cells or casts. Results of a work-up for acute renal failure were strongly positive for myeloperoxidase and negative for antinuclear antibodies, proteinase 3, anti–glomerular basement membrane antibodies, hepatitis B/C, and monoclonal protein.</description>
  261.      <dc:title>Fast-Tracking Renal Failure: A Classic Case of ANCA-Associated Glomerulonephritis</dc:title>
  262.      <dc:creator>Vijayvardhan Kamalumpundi, Alyssa K.W. Maclean, Mariam P. Alexander</dc:creator>
  263.      <dc:identifier>10.1016/j.mayocp.2025.02.002</dc:identifier>
  264.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  265.      <dc:date>2025-04-08</dc:date>
  266.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  267.      <prism:publicationDate>2025-04-08</prism:publicationDate>
  268.      <prism:volume>100</prism:volume>
  269.      <prism:number>5</prism:number>
  270.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  271.      <prism:section>Medical image</prism:section>
  272.      <prism:startingPage>776</prism:startingPage>
  273.      <prism:endingPage>777</prism:endingPage>
  274.   </item>
  275.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00650-5/fulltext?rss=yes">
  276.      <title>Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk</title>
  277.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00650-5/fulltext?rss=yes</link>
  278.      <description>To assess the long-term association between benign prostatic hyperplasia (BPH) and chronic kidney disease (CKD) while considering the potential role of BPH medications in any observed associations.</description>
  279.      <dc:title>Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk</dc:title>
  280.      <dc:creator>Chenxi Ouyang, Liang Zhou, Jiahao Liu, Long Wang, Yao Lu</dc:creator>
  281.      <dc:identifier>10.1016/j.mayocp.2024.11.024</dc:identifier>
  282.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  283.      <dc:date>2025-04-08</dc:date>
  284.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  285.      <prism:publicationDate>2025-04-08</prism:publicationDate>
  286.      <prism:volume>100</prism:volume>
  287.      <prism:number>5</prism:number>
  288.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  289.      <prism:section>Original article</prism:section>
  290.      <prism:startingPage>790</prism:startingPage>
  291.      <prism:endingPage>800</prism:endingPage>
  292.   </item>
  293.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00623-2/fulltext?rss=yes">
  294.      <title>Trends in the Incidence of Hypertension Among Healthy Adults Across 6 Decades</title>
  295.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00623-2/fulltext?rss=yes</link>
  296.      <description>To determine long-term trends in the incidence of hypertension.</description>
  297.      <dc:title>Trends in the Incidence of Hypertension Among Healthy Adults Across 6 Decades</dc:title>
  298.      <dc:creator>Andrew D. Rule, Daniel C. Waller, Erika S. Helgeson, Alanna M. Chamberlain, Alison C. Saiki, Eliabe Silva de Abreu, Salma Kiwan, Naim S. Issa, Aidan F. Mullan, Gary L. Schwartz, Arthur J. Matas, David M. Vock</dc:creator>
  299.      <dc:identifier>10.1016/j.mayocp.2024.10.025</dc:identifier>
  300.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  301.      <dc:date>2025-04-08</dc:date>
  302.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  303.      <prism:publicationDate>2025-04-08</prism:publicationDate>
  304.      <prism:volume>100</prism:volume>
  305.      <prism:number>5</prism:number>
  306.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  307.      <prism:section>Original article</prism:section>
  308.      <prism:startingPage>778</prism:startingPage>
  309.      <prism:endingPage>789</prism:endingPage>
  310.   </item>
  311.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00142-9/fulltext?rss=yes">
  312.      <title>Locomotor Brachii Sign in Absence of Severe Aortic Regurgitation</title>
  313.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00142-9/fulltext?rss=yes</link>
  314.      <description>A man in his late 80s with a history of hypertension and chronic aortic regurgitation presented for routine follow-up without symptoms. Physical examination findings were remarkable for a widened pulse pressure (blood pressure, 178/60 mm Hg; equal bilaterally) and a grade 2/6 early diastolic murmur heard loudest at the base. The left upper extremity brachial artery was tortuous and visibly pulsatile, enlarging in systole and rapidly collapsing in diastole (Figure; Supplemental Video, available online at http://www.mayoclinicproceedings.org)—a finding known as locomotor brachii sign.</description>
  315.      <dc:title>Locomotor Brachii Sign in Absence of Severe Aortic Regurgitation</dc:title>
  316.      <dc:creator>Jesse Calestine, Moses Mathur</dc:creator>
  317.      <dc:identifier>10.1016/j.mayocp.2025.03.002</dc:identifier>
  318.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  319.      <dc:date>2025-04-07</dc:date>
  320.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  321.      <prism:publicationDate>2025-04-07</prism:publicationDate>
  322.      <prism:volume>100</prism:volume>
  323.      <prism:number>5</prism:number>
  324.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  325.      <prism:section>Medical image</prism:section>
  326.      <prism:startingPage>912</prism:startingPage>
  327.   </item>
  328.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00113-2/fulltext?rss=yes">
  329.      <title>Trends and Sociodemographic Disparities in the Prevalence of Obesity Among US Children and Adolescents, 2011 to 2023</title>
  330.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00113-2/fulltext?rss=yes</link>
  331.      <description>Childhood obesity is a significant public health concern. It was reported that the COVID-19 pandemic may have exacerbated this issue because of lifestyle changes.1 We aimed to reevaluate trends in the prevalence of obesity among children and adolescents in the United States using the latest nationally representative data from 2011 to 2023. Furthermore, we assessed how these trends vary across demographic subgroups.</description>
  332.      <dc:title>Trends and Sociodemographic Disparities in the Prevalence of Obesity Among US Children and Adolescents, 2011 to 2023</dc:title>
  333.      <dc:creator>Jia-Shuan Huang, Zhao-Cong He, Rema Ramakrishnan, Min-Shan Lu, Dan-Tong Shao, Xiu Qiu, Jian-Rong He</dc:creator>
  334.      <dc:identifier>10.1016/j.mayocp.2025.02.020</dc:identifier>
  335.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  336.      <dc:date>2025-04-07</dc:date>
  337.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  338.      <prism:publicationDate>2025-04-07</prism:publicationDate>
  339.      <prism:volume>100</prism:volume>
  340.      <prism:number>5</prism:number>
  341.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  342.      <prism:section>Research letter</prism:section>
  343.      <prism:startingPage>917</prism:startingPage>
  344.      <prism:endingPage>919</prism:endingPage>
  345.   </item>
  346.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00083-7/fulltext?rss=yes">
  347.      <title>Reversal of Coma With Trendelenburg Position in Spontaneous Intracranial Hypotension</title>
  348.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00083-7/fulltext?rss=yes</link>
  349.      <description>Spontaneous intracranial hypotension (SIH) is a clinical and radiologic syndrome caused by spinal leakage of cerebrospinal fluid due to a dural tear, leaking meningeal diverticulum, or cerebrospinal fluid–venous fistula. Whereas the hallmark clinical feature of SIH is orthostatic headache, in rare instances, life-threatening complications may include altered consciousness and even coma as a result of extreme downward displacement of the midbrain and brainstem. We describe the clinical features, neuroimaging findings, management strategies, and short-term outcomes of 2 unique cases of severe SIH and the role of Trendelenburg position to reverse coma.</description>
  350.      <dc:title>Reversal of Coma With Trendelenburg Position in Spontaneous Intracranial Hypotension</dc:title>
  351.      <dc:creator>Tony Zhang, Sara J. Hooshmand, Nathaniel P. Rogers, David O. Sohutskay, Michel Toledano, Ajay A. Madhavan, John L. Atkinson, Jeremy L. Fogelson, Alejandro A. Rabinstein, Jeremy K. Cutsforth-Gregory, Rafid Mustafa</dc:creator>
  352.      <dc:identifier>10.1016/j.mayocp.2025.02.006</dc:identifier>
  353.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  354.      <dc:date>2025-04-07</dc:date>
  355.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  356.      <prism:publicationDate>2025-04-07</prism:publicationDate>
  357.      <prism:volume>100</prism:volume>
  358.      <prism:number>5</prism:number>
  359.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  360.      <prism:section>Case report</prism:section>
  361.      <prism:startingPage>906</prism:startingPage>
  362.      <prism:endingPage>911</prism:endingPage>
  363.   </item>
  364.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00047-3/fulltext?rss=yes">
  365.      <title>Imaging the Histopathologic Spectrum of Substantia Nigra Changes in Parkinson Disease Using 7T MRI</title>
  366.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00047-3/fulltext?rss=yes</link>
  367.      <description>A woman in her early 50s presented with 8 years of progressive right-sided motor symptoms concerning for parkinsonism. On examination, she exhibited moderate rigidity and bradykinesia in the right upper and lower extremities, accompanied by mild postural myoclonus. Additionally, right hemidystonia was observed, characterized by toe curling, flexion of the right upper extremity, and right knee flexion during ambulation. The gait examination also revealed difficulty rising from a seated position to standing, moderately reduced stride length, and diminished right arm swing.</description>
  368.      <dc:title>Imaging the Histopathologic Spectrum of Substantia Nigra Changes in Parkinson Disease Using 7T MRI</dc:title>
  369.      <dc:creator>Erik H. Middlebrooks, Xiangzhi Zhou, Ashley B. Peña</dc:creator>
  370.      <dc:identifier>10.1016/j.mayocp.2025.02.001</dc:identifier>
  371.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  372.      <dc:date>2025-04-07</dc:date>
  373.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  374.      <prism:publicationDate>2025-04-07</prism:publicationDate>
  375.      <prism:volume>100</prism:volume>
  376.      <prism:number>5</prism:number>
  377.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  378.      <prism:section>Medical image</prism:section>
  379.      <prism:startingPage>854</prism:startingPage>
  380.      <prism:endingPage>855</prism:endingPage>
  381.   </item>
  382.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00363-X/fulltext?rss=yes">
  383.      <title>71-Year-Old Man With Chest Pain and Shortness of Breath</title>
  384.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00363-X/fulltext?rss=yes</link>
  385.      <description>A 71-year-old man presented with persistent nonpositional shortness of breath and chest pain. Two weeks earlier, he described experiencing an episode of severe crushing substernal chest pain with associated shortness of breath, lasting approximately 1 to 2 hours. The patient did not seek medical care following the episode.</description>
  386.      <dc:title>71-Year-Old Man With Chest Pain and Shortness of Breath</dc:title>
  387.      <dc:creator>Brent J. Gawey, Teodora Donisan, Nandan S. Anavekar</dc:creator>
  388.      <dc:identifier>10.1016/j.mayocp.2024.05.033</dc:identifier>
  389.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  390.      <dc:date>2025-04-07</dc:date>
  391.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  392.      <prism:publicationDate>2025-04-07</prism:publicationDate>
  393.      <prism:volume>100</prism:volume>
  394.      <prism:number>5</prism:number>
  395.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  396.      <prism:section>Residents’ Clinic</prism:section>
  397.      <prism:startingPage>900</prism:startingPage>
  398.      <prism:endingPage>905</prism:endingPage>
  399.   </item>
  400.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00488-9/fulltext?rss=yes">
  401.      <title>Cardiorespiratory Fitness and Mortality in Patients With Chronic Kidney Disease</title>
  402.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00488-9/fulltext?rss=yes</link>
  403.      <description>To assess the association between objectively measured cardiorespiratory fitness (CRF) and mortality in patients with chronic kidney disease (CKD).</description>
  404.      <dc:title>Cardiorespiratory Fitness and Mortality in Patients With Chronic Kidney Disease</dc:title>
  405.      <dc:creator>Xuemei Sui, Peter Kokkinos, Charles Faselis, Immanuel Babu Henry Samuel, Andreas Pittaras, Jared Gollie, Samir Patel, Carl J. Lavie, Jiajia Zhang, Jonathan Myers</dc:creator>
  406.      <dc:identifier>10.1016/j.mayocp.2024.09.023</dc:identifier>
  407.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  408.      <dc:date>2025-04-04</dc:date>
  409.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  410.      <prism:publicationDate>2025-04-04</prism:publicationDate>
  411.      <prism:section>Original Article</prism:section>
  412.   </item>
  413.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00696-7/fulltext?rss=yes">
  414.      <title>Causal Associations of Insomnia With Chronic Kidney Diseases and Underlying Blood Proteins: An Observational and Mendelian Randomization Study</title>
  415.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00696-7/fulltext?rss=yes</link>
  416.      <description>To investigate the causal association between insomnia and chronic kidney disease (CKD) and to explore the underlying protein pathways.</description>
  417.      <dc:title>Causal Associations of Insomnia With Chronic Kidney Diseases and Underlying Blood Proteins: An Observational and Mendelian Randomization Study</dc:title>
  418.      <dc:creator>Kunying Wang, Shuo Ye, Hongliang Feng, Yannis Yan Liang, Sheng Guo, Rui Zheng, Yujing Zhou, Guangbo Jia, Lu Qi, Guoan Zhao, Jihui Zhang, Sizhi Ai</dc:creator>
  419.      <dc:identifier>10.1016/j.mayocp.2024.12.020</dc:identifier>
  420.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  421.      <dc:date>2025-03-31</dc:date>
  422.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  423.      <prism:publicationDate>2025-03-31</prism:publicationDate>
  424.      <prism:section>Original article</prism:section>
  425.   </item>
  426.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00692-X/fulltext?rss=yes">
  427.      <title>Proteomic Profile of Ischemic Heart Disease in Heart Failure: A Community Study</title>
  428.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00692-X/fulltext?rss=yes</link>
  429.      <description>To investigate the clinical characteristics, outcomes, and proteomic profiles of prevalent ischemic heart disease (IHD) in heart failure (HF) in a clinically phenotyped cohort.</description>
  430.      <dc:title>Proteomic Profile of Ischemic Heart Disease in Heart Failure: A Community Study</dc:title>
  431.      <dc:creator>Kayode O. Kuku, Maryam Hashemian, Jungnam Joo, Joseph J. Shearer, Carolina G. Downie, Mohit Aggarwal, Suzette J. Bielinski, Véronique L. Roger</dc:creator>
  432.      <dc:identifier>10.1016/j.mayocp.2024.12.016</dc:identifier>
  433.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  434.      <dc:date>2025-03-31</dc:date>
  435.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  436.      <prism:publicationDate>2025-03-31</prism:publicationDate>
  437.      <prism:section>Original article</prism:section>
  438.   </item>
  439.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00686-4/fulltext?rss=yes">
  440.      <title>Safety of Acamprosate in Patients With Alcohol-Associated Liver Disease: A Single-Arm Phase 2 Trial</title>
  441.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00686-4/fulltext?rss=yes</link>
  442.      <description>To investigate the safety of acamprosate, a Food and Drug Administration–approved medication for alcohol use disorder, in patients with alcohol-associated liver disease.</description>
  443.      <dc:title>Safety of Acamprosate in Patients With Alcohol-Associated Liver Disease: A Single-Arm Phase 2 Trial</dc:title>
  444.      <dc:creator>Tiffany Wu, Omar Y. Mousa, Tasha Kulai, Cori Larson, Amy Olofson, Patrick S. Kamath, Vijay H. Shah, Timucin Taner, William Sanchez, Douglas A. Simonetto</dc:creator>
  445.      <dc:identifier>10.1016/j.mayocp.2024.12.013</dc:identifier>
  446.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  447.      <dc:date>2025-03-26</dc:date>
  448.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  449.      <prism:publicationDate>2025-03-26</prism:publicationDate>
  450.      <prism:section>Original article</prism:section>
  451.   </item>
  452.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00075-8/fulltext?rss=yes">
  453.      <title>Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis</title>
  454.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00075-8/fulltext?rss=yes</link>
  455.      <description>To evaluate the efficacy of combination lipid-lowering therapy (LLT) compared with statin monotherapy for low-density lipoprotein cholesterol (LDL-C) reduction, associated adverse events, and outcomes.</description>
  456.      <dc:title>Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis</dc:title>
  457.      <dc:creator>Maciej Banach, Vikash Jaiswal, Song Peng Ang, Aanchal Sawhney, Novonil Deb, Pierre Amarenco, Dan Gaita, Zeljko Reiner, Ivan Pećin, Carl J. Lavie, Peter E. Penson, Peter P. Toth, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP)</dc:creator>
  458.      <dc:identifier>10.1016/j.mayocp.2025.01.018</dc:identifier>
  459.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  460.      <dc:date>2025-03-23</dc:date>
  461.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  462.      <prism:publicationDate>2025-03-23</prism:publicationDate>
  463.      <prism:section>Original Article</prism:section>
  464.   </item>
  465.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00482-8/fulltext?rss=yes">
  466.      <title>Association Between Vacation Characteristics and Career Intentions of US Physicians—A Cross-Sectional Analysis</title>
  467.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00482-8/fulltext?rss=yes</link>
  468.      <description>To assess the association between physicians’ vacation characteristics and career intentions.</description>
  469.      <dc:title>Association Between Vacation Characteristics and Career Intentions of US Physicians—A Cross-Sectional Analysis</dc:title>
  470.      <dc:creator>Christine A. Sinsky, Purva Shah, Lindsey E. Carlasare, Tait D. Shanafelt</dc:creator>
  471.      <dc:identifier>10.1016/j.mayocp.2024.09.020</dc:identifier>
  472.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  473.      <dc:date>2025-03-07</dc:date>
  474.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  475.      <prism:publicationDate>2025-03-07</prism:publicationDate>
  476.      <prism:volume>100</prism:volume>
  477.      <prism:number>5</prism:number>
  478.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  479.      <prism:section>Original article</prism:section>
  480.      <prism:startingPage>814</prism:startingPage>
  481.      <prism:endingPage>827</prism:endingPage>
  482.   </item>
  483.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00479-8/fulltext?rss=yes">
  484.      <title>Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021</title>
  485.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00479-8/fulltext?rss=yes</link>
  486.      <description>To determine whether the risks of infectious mononucleosis (IM) and serious IM outcomes are changing over time.</description>
  487.      <dc:title>Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021</dc:title>
  488.      <dc:creator>Jennifer L. St. Sauver, Robert M. Jacobson, Susan A. Weston, Chun Fan, Philip O. Buck, Susan A. Hall</dc:creator>
  489.      <dc:identifier>10.1016/j.mayocp.2024.09.017</dc:identifier>
  490.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  491.      <dc:date>2025-03-06</dc:date>
  492.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  493.      <prism:publicationDate>2025-03-06</prism:publicationDate>
  494.      <prism:section>Original Article</prism:section>
  495.   </item>
  496.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00480-4/fulltext?rss=yes">
  497.      <title>Self-Monitoring of Blood Pressure and Feedback via Mobile App in Treatment of Uncontrolled Hypertension: The SMART-BP Randomized Clinical Trial</title>
  498.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00480-4/fulltext?rss=yes</link>
  499.      <description>To evaluate the effects of mobile apps with tailored recommendations on changes in blood pressure (BP) and drug adherence.</description>
  500.      <dc:title>Self-Monitoring of Blood Pressure and Feedback via Mobile App in Treatment of Uncontrolled Hypertension: The SMART-BP Randomized Clinical Trial</dc:title>
  501.      <dc:creator>Minjae Yoon, Taeho Hur, Sung-Ji Park, Sang-Ho Jo, Eung Ju Kim, Soo-Joong Kim, Musarrat Hussain, Cam-Hao Hua, Sungyoung Lee, Dong-Ju Choi</dc:creator>
  502.      <dc:identifier>10.1016/j.mayocp.2024.09.018</dc:identifier>
  503.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  504.      <dc:date>2025-03-05</dc:date>
  505.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  506.      <prism:publicationDate>2025-03-05</prism:publicationDate>
  507.      <prism:volume>100</prism:volume>
  508.      <prism:number>5</prism:number>
  509.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  510.      <prism:section>Original article</prism:section>
  511.      <prism:startingPage>840</prism:startingPage>
  512.      <prism:endingPage>853</prism:endingPage>
  513.   </item>
  514.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00618-9/fulltext?rss=yes">
  515.      <title>A Contemporary Assessment of the Prevalence of Chronic Diseases That Contribute to Health Care Utilization</title>
  516.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00618-9/fulltext?rss=yes</link>
  517.      <description>To investigate the most prevalent diagnosed conditions contributing to health care visitations in a defined US population by age and racial group, educational level, and socioeconomic deprivation.</description>
  518.      <dc:title>A Contemporary Assessment of the Prevalence of Chronic Diseases That Contribute to Health Care Utilization</dc:title>
  519.      <dc:creator>Harold I. Salmons, Dirk R. Larson, Rachel E. Gullerud, Hilal Maradit Kremers, Jennifer L. St. Sauver, Arjun S. Sebastian, Daniel J. Berry, Jennifer J. Westendorf, Matthew P. Abdel</dc:creator>
  520.      <dc:identifier>10.1016/j.mayocp.2024.10.023</dc:identifier>
  521.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  522.      <dc:date>2025-03-04</dc:date>
  523.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  524.      <prism:publicationDate>2025-03-04</prism:publicationDate>
  525.      <prism:section>Original article</prism:section>
  526.   </item>
  527.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00663-3/fulltext?rss=yes">
  528.      <title>Lower Rates of Abdominal Aortic Aneurysm Repair and Higher Long-term Aortic Mortality in Women Compared With Men: Results of a Population-Based Study Spanning 4 Decades</title>
  529.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00663-3/fulltext?rss=yes</link>
  530.      <description>To determine the population-level impact of screening and endovascular repair as well as mortality in women with abdominal aortic aneurysms (AAAs).</description>
  531.      <dc:title>Lower Rates of Abdominal Aortic Aneurysm Repair and Higher Long-term Aortic Mortality in Women Compared With Men: Results of a Population-Based Study Spanning 4 Decades</dc:title>
  532.      <dc:creator>Indrani Sen, Jill Colglazier, Jennifer St. Sauver, William S. Harmsen, Jay Mandrekar, Manju Kalra</dc:creator>
  533.      <dc:identifier>10.1016/j.mayocp.2024.11.027</dc:identifier>
  534.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  535.      <dc:date>2025-02-20</dc:date>
  536.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  537.      <prism:publicationDate>2025-02-20</prism:publicationDate>
  538.      <prism:section>Original article</prism:section>
  539.   </item>
  540.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00481-6/fulltext?rss=yes">
  541.      <title>Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging</title>
  542.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00481-6/fulltext?rss=yes</link>
  543.      <description>To assess the relative predictors of mortality risk in a contemporary cohort of patients referred for stress single-photon emission computed tomography myocardial perfusion imaging in whom all relevant risk factors and cardiac-related comorbidities were evaluated at the time of cardiac stress testing.</description>
  544.      <dc:title>Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging</dc:title>
  545.      <dc:creator>Alan Rozanski, Heidi Gransar, Robert J.H. Miller, Donghee Han, Sean W. Hayes, John D. Friedman, Louise Thomson, Carl J. Lavie, Daniel S. Berman</dc:creator>
  546.      <dc:identifier>10.1016/j.mayocp.2024.09.019</dc:identifier>
  547.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  548.      <dc:date>2025-02-19</dc:date>
  549.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  550.      <prism:publicationDate>2025-02-19</prism:publicationDate>
  551.      <prism:volume>100</prism:volume>
  552.      <prism:number>5</prism:number>
  553.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  554.      <prism:section>Original Article</prism:section>
  555.      <prism:startingPage>828</prism:startingPage>
  556.      <prism:endingPage>839</prism:endingPage>
  557.   </item>
  558.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00666-9/fulltext?rss=yes">
  559.      <title>Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure</title>
  560.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00666-9/fulltext?rss=yes</link>
  561.      <description>To compare dialysis transition patterns of chronic kidney disease (CKD) patients with heart failure (HF) and without HF, including inpatient “crash start” initiation of long-term (“maintenance”) dialysis, early dialysis initiation as evaluated by estimated glomerular filtration rate (eGFR), and rate of central venous catheter (CVC) use for hemodialysis.</description>
  562.      <dc:title>Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure</dc:title>
  563.      <dc:creator>Mitchell E. Flagg, Simran K. Bhandari, Katherine J. Pak, Hui Zhou, Sally F. Shaw, Jiaxiao M. Shi, Connie M. Rhee, Benjamin I. Broder, John J. Sim</dc:creator>
  564.      <dc:identifier>10.1016/j.mayocp.2024.11.029</dc:identifier>
  565.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  566.      <dc:date>2025-02-18</dc:date>
  567.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  568.      <prism:publicationDate>2025-02-18</prism:publicationDate>
  569.      <prism:section>Original article</prism:section>
  570.   </item>
  571.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00616-5/fulltext?rss=yes">
  572.      <title>Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021</title>
  573.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00616-5/fulltext?rss=yes</link>
  574.      <description>To explore the increasing incidence of gastrointestinal (GI) cancers and related risk factors in younger patients.</description>
  575.      <dc:title>Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021</dc:title>
  576.      <dc:creator>Pojsakorn Danpanichkul, Kanokphong Suparan, Thanida Auttapracha, Primrose Tothanarungroj, Siwanart Kongarin, Krittameth Rakwong, Darren Jun Hao Tan, Banthoon Sukphutanan, Mark D. Muthiah, Daniel Tung, Junpeng Luo, Asahiro Morishita, En Ying Tan, Hirokazu Takahashi, Omar Y. Mousa, Rashid N. Lui, Mazen Noureddin, Donghee Kim, Denise M. Harnois, Ju Dong Yang, Lewis R. Roberts, Michael B. Wallace, Karn Wijarnpreecha</dc:creator>
  577.      <dc:identifier>10.1016/j.mayocp.2024.10.021</dc:identifier>
  578.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  579.      <dc:date>2025-02-11</dc:date>
  580.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  581.      <prism:publicationDate>2025-02-11</prism:publicationDate>
  582.      <prism:section>Original article</prism:section>
  583.   </item>
  584.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00615-3/fulltext?rss=yes">
  585.      <title>Cross-sectional and Longitudinal Associations Between Family History of Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia and Their Prevalence and Incidence</title>
  586.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00615-3/fulltext?rss=yes</link>
  587.      <description>To examine the association between a positive family history (parents, siblings, and grandparents) of type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia and their prevalence and incidence in the same population.</description>
  588.      <dc:title>Cross-sectional and Longitudinal Associations Between Family History of Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia and Their Prevalence and Incidence</dc:title>
  589.      <dc:creator>Izumi Ikeda, Risa Igarashi, Kazuya Fujihara, Yasunaga Takeda, Efrem d'Ávila Ferreira, Khin Lay Mon, Satoru Kodama, Yasumichi Mori, Takashi Kadowaki, Ritsuko Honda, Yasuji Arase, Hirohito Sone</dc:creator>
  590.      <dc:identifier>10.1016/j.mayocp.2024.10.020</dc:identifier>
  591.      <dc:source>Mayo Clinic Proceedings (2025)</dc:source>
  592.      <dc:date>2025-01-29</dc:date>
  593.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  594.      <prism:publicationDate>2025-01-29</prism:publicationDate>
  595.      <prism:section>Original article</prism:section>
  596.   </item>
  597.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00216-2/fulltext?rss=yes">
  598.      <title>Highlights from the Current Issue – Audiovisual Summary</title>
  599.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00216-2/fulltext?rss=yes</link>
  600.      <description>Karl A. Nath, MBChB, Editor-in-Chief of Mayo Clinic Proceedings, discusses the Editor’s Choice and Highlights articles appearing in the May 2025 issue.</description>
  601.      <dc:title>Highlights from the Current Issue – Audiovisual Summary</dc:title>
  602.      <dc:creator>Karl A. Nath</dc:creator>
  603.      <dc:identifier>10.1016/j.mayocp.2025.04.010</dc:identifier>
  604.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  605.      <dc:date>2025-05</dc:date>
  606.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  607.      <prism:publicationDate>2025-05</prism:publicationDate>
  608.      <prism:volume>100</prism:volume>
  609.      <prism:number>5</prism:number>
  610.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  611.      <prism:section>Issue summary</prism:section>
  612.      <prism:startingPage>e1</prism:startingPage>
  613.   </item>
  614.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00190-9/fulltext?rss=yes">
  615.      <title>General Information</title>
  616.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00190-9/fulltext?rss=yes</link>
  617.      <dc:title>General Information</dc:title>
  618.      <dc:identifier>10.1016/S0025-6196(25)00190-9</dc:identifier>
  619.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  620.      <dc:date>2025-05</dc:date>
  621.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  622.      <prism:publicationDate>2025-05</prism:publicationDate>
  623.      <prism:volume>100</prism:volume>
  624.      <prism:number>5</prism:number>
  625.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  626.      <prism:startingPage>A7</prism:startingPage>
  627.   </item>
  628.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00189-2/fulltext?rss=yes">
  629.      <title>Table of Contents</title>
  630.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00189-2/fulltext?rss=yes</link>
  631.      <dc:title>Table of Contents</dc:title>
  632.      <dc:identifier>10.1016/S0025-6196(25)00189-2</dc:identifier>
  633.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  634.      <dc:date>2025-05</dc:date>
  635.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  636.      <prism:publicationDate>2025-05</prism:publicationDate>
  637.      <prism:volume>100</prism:volume>
  638.      <prism:number>5</prism:number>
  639.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  640.      <prism:startingPage>A3</prism:startingPage>
  641.      <prism:endingPage>A6</prism:endingPage>
  642.   </item>
  643.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00188-0/fulltext?rss=yes">
  644.      <title>Editorial Board</title>
  645.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00188-0/fulltext?rss=yes</link>
  646.      <dc:title>Editorial Board</dc:title>
  647.      <dc:identifier>10.1016/S0025-6196(25)00188-0</dc:identifier>
  648.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  649.      <dc:date>2025-05</dc:date>
  650.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  651.      <prism:publicationDate>2025-05</prism:publicationDate>
  652.      <prism:volume>100</prism:volume>
  653.      <prism:number>5</prism:number>
  654.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  655.      <prism:startingPage>A1</prism:startingPage>
  656.      <prism:endingPage>A2</prism:endingPage>
  657.   </item>
  658.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00180-6/fulltext?rss=yes">
  659.      <title>In the Limelight: May 2025</title>
  660.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00180-6/fulltext?rss=yes</link>
  661.      <description>This month’s feature highlights three articles that appear in the current issue of Mayo Clinic Proceedings. These articles are also featured on the Mayo Clinic Proceedings’ YouTube Channel (https://youtu.be/w5oc3LrhO8g).</description>
  662.      <dc:title>In the Limelight: May 2025</dc:title>
  663.      <dc:creator>Karl A. Nath</dc:creator>
  664.      <dc:identifier>10.1016/j.mayocp.2025.03.025</dc:identifier>
  665.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  666.      <dc:date>2025-05</dc:date>
  667.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  668.      <prism:publicationDate>2025-05</prism:publicationDate>
  669.      <prism:volume>100</prism:volume>
  670.      <prism:number>5</prism:number>
  671.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  672.      <prism:section>Editorial</prism:section>
  673.      <prism:startingPage>761</prism:startingPage>
  674.      <prism:endingPage>763</prism:endingPage>
  675.   </item>
  676.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00149-1/fulltext?rss=yes">
  677.      <title>The Kidney-Prostate Axis</title>
  678.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00149-1/fulltext?rss=yes</link>
  679.      <description>The relationship between benign prostatic hypertrophy (BPH) and chronic kidney disease (CKD), 2 common conditions of the aging population, is evaluated in a study by Ouyang et al1 in this issue of Mayo Clinic Proceedings. These 2 conditions have been linked in previous studies, with lower urinary tract symptoms, urinary retention,2 and low urinary peak flow rate3 associating with a higher risk of CKD in cross-sectional studies of community-dwelling adults. In this study, the authors used the UK Biobank to investigate the association of BPH with the development of CKD and end-stage kidney disease (ESKD) in a longitudinal cohort study.</description>
  680.      <dc:title>The Kidney-Prostate Axis</dc:title>
  681.      <dc:creator>Andrea G. Kattah</dc:creator>
  682.      <dc:identifier>10.1016/j.mayocp.2025.03.009</dc:identifier>
  683.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  684.      <dc:date>2025-05</dc:date>
  685.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  686.      <prism:publicationDate>2025-05</prism:publicationDate>
  687.      <prism:volume>100</prism:volume>
  688.      <prism:number>5</prism:number>
  689.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  690.      <prism:section>Editorial</prism:section>
  691.      <prism:startingPage>770</prism:startingPage>
  692.      <prism:endingPage>772</prism:endingPage>
  693.   </item>
  694.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00148-X/fulltext?rss=yes">
  695.      <title>Incident Hypertension: Much Ado About Something</title>
  696.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00148-X/fulltext?rss=yes</link>
  697.      <description>It is important to define a term, even a common term like incidence, when considering its importance as a public health concern. Using the Oxford English Dictionary our library at the University of Pennsylvania offers, I note that there are 10 meanings for the word incidence, 4 of which are considered obsolete. The definition I think most relevant to the discussion that ensues here is this one:“Manner of falling upon or affecting in any way; the range or scope of a thing, the extent of its influence or effects.” (incidence, n.</description>
  698.      <dc:title>Incident Hypertension: Much Ado About Something</dc:title>
  699.      <dc:creator>Raymond R. Townsend</dc:creator>
  700.      <dc:identifier>10.1016/j.mayocp.2025.03.008</dc:identifier>
  701.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  702.      <dc:date>2025-05</dc:date>
  703.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  704.      <prism:publicationDate>2025-05</prism:publicationDate>
  705.      <prism:volume>100</prism:volume>
  706.      <prism:number>5</prism:number>
  707.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  708.      <prism:section>Editorial</prism:section>
  709.      <prism:startingPage>767</prism:startingPage>
  710.      <prism:endingPage>769</prism:endingPage>
  711.   </item>
  712.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00147-8/fulltext?rss=yes">
  713.      <title>American Legion Citation to Charles H. and William J. Mayo</title>
  714.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00147-8/fulltext?rss=yes</link>
  715.      <description>Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of Mayo Clinic Proceedings features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses.</description>
  716.      <dc:title>American Legion Citation to Charles H. and William J. Mayo</dc:title>
  717.      <dc:creator>Margaret R. Wentz</dc:creator>
  718.      <dc:identifier>10.1016/j.mayocp.2025.03.007</dc:identifier>
  719.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  720.      <dc:date>2025-05</dc:date>
  721.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  722.      <prism:publicationDate>2025-05</prism:publicationDate>
  723.      <prism:volume>100</prism:volume>
  724.      <prism:number>5</prism:number>
  725.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  726.      <prism:section>Art at mayo clinic</prism:section>
  727.      <prism:startingPage>925</prism:startingPage>
  728.   </item>
  729.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00146-6/fulltext?rss=yes">
  730.      <title>Easter Seals, Christmas Seals, and Other Medical “Cinderella” Stamps</title>
  731.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00146-6/fulltext?rss=yes</link>
  732.      <description>What are Cinderella stamps? The name evokes a centuries-old folktale that Walt Disney turned into a classic animated film in 1950. But Cinderella stamps have nothing to do with big revelations about underestimated heroines who lose glass slippers.</description>
  733.      <dc:title>Easter Seals, Christmas Seals, and Other Medical “Cinderella” Stamps</dc:title>
  734.      <dc:creator>David P. Steensma</dc:creator>
  735.      <dc:identifier>10.1016/j.mayocp.2025.03.006</dc:identifier>
  736.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  737.      <dc:date>2025-05</dc:date>
  738.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  739.      <prism:publicationDate>2025-05</prism:publicationDate>
  740.      <prism:volume>100</prism:volume>
  741.      <prism:number>5</prism:number>
  742.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  743.      <prism:section>History of medicine</prism:section>
  744.      <prism:startingPage>922</prism:startingPage>
  745.      <prism:endingPage>924</prism:endingPage>
  746.   </item>
  747.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00145-4/fulltext?rss=yes">
  748.      <title>Mayo Clinic Proceedings and the Development of Echocardiography</title>
  749.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00145-4/fulltext?rss=yes</link>
  750.      <description>Mayo Clinic Proceedings has long been a trusted source of information for echocardiography with the publication of seminal papers highlighting developments and progress in the field during a period spanning 50 years. Many of the pioneering developments in the field of echocardiography took place at Mayo Clinic. For example, in a 1975 article using M-mode echocardiography, the methodology of the first version of “contrast” echocardiography was described: the appearance of “clouds of echoes” after injection of indocyanine green during cardiac catheterization allowed the recognition of vascular structures, valvular incompetence, and shunts.</description>
  751.      <dc:title>Mayo Clinic Proceedings and the Development of Echocardiography</dc:title>
  752.      <dc:creator>Patricia A. Pellikka</dc:creator>
  753.      <dc:identifier>10.1016/j.mayocp.2025.03.005</dc:identifier>
  754.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  755.      <dc:date>2025-05</dc:date>
  756.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  757.      <prism:publicationDate>2025-05</prism:publicationDate>
  758.      <prism:volume>100</prism:volume>
  759.      <prism:number>5</prism:number>
  760.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  761.      <prism:section>Editorial</prism:section>
  762.      <prism:startingPage>764</prism:startingPage>
  763.      <prism:endingPage>766</prism:endingPage>
  764.   </item>
  765.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00144-2/fulltext?rss=yes">
  766.      <title>Multiple Sclerosis, NMOSD, and the Risk of Autoimmune Diseases</title>
  767.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00144-2/fulltext?rss=yes</link>
  768.      <description>Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are both immune-mediated diseases of the central nervous system. Although they share similar clinical features, there are also key distinctions between them. MS results from an immune-mediated attack on the myelin sheath surrounding axons in the central nervous system, leading to inflammation and subsequent nerve damage. NMOSD, on the other hand, encompasses a group of inflammatory diseases primarily affecting the optic nerves and spinal cord.</description>
  769.      <dc:title>Multiple Sclerosis, NMOSD, and the Risk of Autoimmune Diseases</dc:title>
  770.      <dc:creator>Øivind Torkildsen</dc:creator>
  771.      <dc:identifier>10.1016/j.mayocp.2025.03.004</dc:identifier>
  772.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  773.      <dc:date>2025-05</dc:date>
  774.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  775.      <prism:publicationDate>2025-05</prism:publicationDate>
  776.      <prism:volume>100</prism:volume>
  777.      <prism:number>5</prism:number>
  778.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  779.      <prism:section>Editorial</prism:section>
  780.      <prism:startingPage>773</prism:startingPage>
  781.      <prism:endingPage>775</prism:endingPage>
  782.   </item>
  783.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00114-4/fulltext?rss=yes">
  784.      <title>Pretreatment With P2Y12 Inhibitors in Contemporary Practice</title>
  785.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00114-4/fulltext?rss=yes</link>
  786.      <description>The management of antiplatelet strategies among patients presenting with acute coronary syndrome (ACS) continues to evolve. Earlier studies have shown ischemic benefit with P2Y12 pretreatment in the setting of ACS; however, large-scale contemporary randomized trials supporting this strategy are lacking. This issue assumes relevance among patients with high bleeding risk or those referred for urgent/emergent coronary artery bypass surgery following coronary angiography. The evolution in the technology of percutaneous coronary intervention since the advent of newer-generation stents with lower risk of stent thrombosis is offset with their delivery in patients with high thrombotic and ischemic risk as the demographics of ACS shift towards the older age group.</description>
  787.      <dc:title>Pretreatment With P2Y12 Inhibitors in Contemporary Practice</dc:title>
  788.      <dc:creator>Mandeep Singh, Marco Valgimigli</dc:creator>
  789.      <dc:identifier>10.1016/j.mayocp.2024.09.031</dc:identifier>
  790.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  791.      <dc:date>2025-05</dc:date>
  792.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  793.      <prism:publicationDate>2025-05</prism:publicationDate>
  794.      <prism:volume>100</prism:volume>
  795.      <prism:number>5</prism:number>
  796.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  797.      <prism:section>Review</prism:section>
  798.      <prism:startingPage>868</prism:startingPage>
  799.      <prism:endingPage>881</prism:endingPage>
  800.   </item>
  801.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00101-6/fulltext?rss=yes">
  802.      <title>Diagnosis and Management of Gastroesophageal Reflux Disease: A Concise Review for Clinicians</title>
  803.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00101-6/fulltext?rss=yes</link>
  804.      <description>Gastroesophageal reflux disease (GERD) is a clinical condition seen frequently by both primary care providers and gastroenterologists. Although it is incredibly common, the diagnosis and management of GERD are not always straightforward. In this review, we summarize the symptoms, pathophysiologic process, and risk factors for GERD. We outline a stepwise approach for the diagnosis of GERD, accounting for the presence of typical and atypical symptoms, in the context of alarm symptoms and comorbid conditions.</description>
  805.      <dc:title>Diagnosis and Management of Gastroesophageal Reflux Disease: A Concise Review for Clinicians</dc:title>
  806.      <dc:creator>Hannah R. Phillips, Amrit K. Kamboj, Cadman L. Leggett</dc:creator>
  807.      <dc:identifier>10.1016/j.mayocp.2025.01.022</dc:identifier>
  808.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  809.      <dc:date>2025-05</dc:date>
  810.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  811.      <prism:publicationDate>2025-05</prism:publicationDate>
  812.      <prism:volume>100</prism:volume>
  813.      <prism:number>5</prism:number>
  814.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  815.      <prism:section>Concise review</prism:section>
  816.      <prism:startingPage>882</prism:startingPage>
  817.      <prism:endingPage>889</prism:endingPage>
  818.   </item>
  819.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00097-7/fulltext?rss=yes">
  820.      <title>Cauda Equina Neuroendocrine Tumor</title>
  821.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00097-7/fulltext?rss=yes</link>
  822.      <description>This intradural spinal tumor was identified in an adult man. On pathologic examination, the tumor was diagnosed as a cauda equina neuroendocrine tumor.</description>
  823.      <dc:title>Cauda Equina Neuroendocrine Tumor</dc:title>
  824.      <dc:creator>Jorge Torres-Mora, Rumeal D. Whaley, Lori A. Erickson</dc:creator>
  825.      <dc:identifier>10.1016/j.mayocp.2025.02.012</dc:identifier>
  826.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  827.      <dc:date>2025-05</dc:date>
  828.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  829.      <prism:publicationDate>2025-05</prism:publicationDate>
  830.      <prism:volume>100</prism:volume>
  831.      <prism:number>5</prism:number>
  832.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  833.      <prism:section>Path to patient image quiz</prism:section>
  834.      <prism:startingPage>920</prism:startingPage>
  835.      <prism:endingPage>921</prism:endingPage>
  836.   </item>
  837.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(25)00082-5/fulltext?rss=yes">
  838.      <title>Effects of Commonly Prescribed Medications on Sleep: A Review of the Literature</title>
  839.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(25)00082-5/fulltext?rss=yes</link>
  840.      <description>This review synthesizes literature on how commonly prescribed medications—antihypertensives, statins, antidepressants, levothyroxine, proton pump inhibitors, phosphodiesterase type 5 inhibitors, and metformin—affect sleep. With many primary care patients reporting sleep issues and more than half of American adults using prescription medications, understanding these effects is essential. Methods included a comprehensive PubMed search of the past decade using relevant medication and sleep-related terms.</description>
  841.      <dc:title>Effects of Commonly Prescribed Medications on Sleep: A Review of the Literature</dc:title>
  842.      <dc:creator>Luke J. Klugherz, Meghna P. Mansukhani, Bhanu Prakash Kolla</dc:creator>
  843.      <dc:identifier>10.1016/j.mayocp.2025.02.005</dc:identifier>
  844.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  845.      <dc:date>2025-05</dc:date>
  846.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  847.      <prism:publicationDate>2025-05</prism:publicationDate>
  848.      <prism:volume>100</prism:volume>
  849.      <prism:number>5</prism:number>
  850.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  851.      <prism:section>Review</prism:section>
  852.      <prism:startingPage>856</prism:startingPage>
  853.      <prism:endingPage>867</prism:endingPage>
  854.   </item>
  855.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00664-5/fulltext?rss=yes">
  856.      <title>Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea</title>
  857.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00664-5/fulltext?rss=yes</link>
  858.      <description>To investigate the risk of autoimmune rheumatic diseases (ARDs) in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) compared with a control population using the Korean National Health Insurance Service database.</description>
  859.      <dc:title>Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea</dc:title>
  860.      <dc:creator>Soonwook Kwon, Kyung-Do Han, Jin Hyung Jung, Eun Bin Cho, Junhee Park, Yeonghee Eun, Hyungjin Kim, Yeon Hak Chung, Dong Wook Shin, Ju-Hong Min</dc:creator>
  861.      <dc:identifier>10.1016/j.mayocp.2024.11.028</dc:identifier>
  862.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  863.      <dc:date>2025-05</dc:date>
  864.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  865.      <prism:publicationDate>2025-05</prism:publicationDate>
  866.      <prism:volume>100</prism:volume>
  867.      <prism:number>5</prism:number>
  868.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  869.      <prism:section>Original article</prism:section>
  870.      <prism:startingPage>801</prism:startingPage>
  871.      <prism:endingPage>813</prism:endingPage>
  872.   </item>
  873.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00365-3/fulltext?rss=yes">
  874.      <title>47-Year-Old Woman Admitted for Pericardial Effusion</title>
  875.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00365-3/fulltext?rss=yes</link>
  876.      <description>A 47-year-old woman with medical history notable for hypothyroidism, hypertension, generalized anxiety disorder, and tobacco use disorder presented as a direct admission to the cardiovascular service from an outside hospital for evaluation and management of pericardial effusion.</description>
  877.      <dc:title>47-Year-Old Woman Admitted for Pericardial Effusion</dc:title>
  878.      <dc:creator>Victoria R. Kalinoski-Dubose, Naba Farooqui, Thomas G. Osborn</dc:creator>
  879.      <dc:identifier>10.1016/j.mayocp.2024.05.035</dc:identifier>
  880.      <dc:source>Mayo Clinic Proceedings 100, 5 (2025)</dc:source>
  881.      <dc:date>2025-05</dc:date>
  882.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
  883.      <prism:publicationDate>2025-05</prism:publicationDate>
  884.      <prism:volume>100</prism:volume>
  885.      <prism:number>5</prism:number>
  886.      <prism:issueIdentifier>S0025-6196(25)X0005-7</prism:issueIdentifier>
  887.      <prism:section>Residents’ Clinic</prism:section>
  888.      <prism:startingPage>890</prism:startingPage>
  889.      <prism:endingPage>894</prism:endingPage>
  890.   </item>
  891. </rdf:RDF>
  892.  

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

  1. Download the "valid RSS" banner.

  2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

  3. Add this HTML to your page (change the image src attribute if necessary):

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=http%3A//www.mayoclinicproceedings.org/current.rss

Home · About · News · Docs · Terms

 
Copyright © 2002-9 Sam Ruby, Mark Pilgrim, Joseph Walton, and Phil Ringnalda